{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:07:09Z","timestamp":1791670029517,"version":"4.3.4"},"reference-count":133,"publisher":"American Association for the Advancement of Science (AAAS)","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073096"],"award-info":[{"award-number":["82073096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303362"],"award-info":[{"award-number":["82303362"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research and Development Plan of Hunan Province","award":["2025JJ30039"],"award-info":[{"award-number":["2025JJ30039"]}]},{"name":"Key Research and Development Plan of Hunan Province","award":["2024DK2006"],"award-info":[{"award-number":["2024DK2006"]}]},{"name":"Scientific Research Program of FuRong Laboratory","award":["No. 2023SK2085"],"award-info":[{"award-number":["No. 2023SK2085"]}]},{"name":"Changsha Natural Science Foundation","award":["kq2403124"],"award-info":[{"award-number":["kq2403124"]}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for the Central Universities of Central South University","doi-asserted-by":"crossref","award":["1053320222607"],"award-info":[{"award-number":["1053320222607"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for the Central Universities of Central South University","doi-asserted-by":"crossref","award":["1053320230888"],"award-info":[{"award-number":["1053320230888"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Biomedical Center of Central South University Institute for Advanced Study, and the Graduate Research and Innovation Projects of Hunan Province","award":["CX20230376"],"award-info":[{"award-number":["CX20230376"]}]},{"name":"Biomedical Center of Central South University Institute for Advanced Study, and the Graduate Research and Innovation Projects of Hunan Province","award":["CX20230120"],"award-info":[{"award-number":["CX20230120"]}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for the Central Universities of Central South University","doi-asserted-by":"crossref","award":["2025ZZTS0141"],"award-info":[{"award-number":["2025ZZTS0141"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["spj.science.org"],"crossmark-restriction":true},"short-container-title":["Research"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Glioblastoma (GBM) is a highly aggressive brain tumor characterized by an immunosuppressive microenvironment that importantly contributes to treatment resistance. Monocyte-derived macrophages (MDMs), which comprise approximately 50% of the cellular population within the GBM microenvironment, represent a major subset of tumor-associated macrophages. These cells drive tumor progression by promoting angiogenesis, immune evasion, and the phenotypic transformation of tumor cells. MDM infiltration is mediated by specific signaling pathways and regulated by the disruption of the blood\u2013brain barrier and tumor-associated hypoxia. Recent technological advances have uncovered substantial heterogeneity among macrophages, including hypoxia-induced, lipid-metabolizing, phagocytic, and interferon-activated subtypes. This functional diversity is shaped by tumor-specific genetic alterations and metabolic reprogramming. Therapeutic approaches focusing on MDMs include inhibiting their recruitment, enhancing phagocytic activity, employing genetically engineered macrophage, and modulating metabolic pathways. While preclinical studies suggest that these approaches may improve efficacy when combined with immune checkpoint inhibitors, the dynamic spatiotemporal heterogeneity and adaptability of macrophages within the tumor microenvironment remain substantial therapeutic challenges. Future development in combination therapies, integrating single-cell multi-omics, spatial metabolic profiling, and targeted interventions, will be critical to precisely modulate MDMs, overcome immune tolerance, and improve patient outcomes.<\/jats:p>","DOI":"10.34133\/research.0836","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T13:33:02Z","timestamp":1753277582000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["New Insights into Monocyte-Derived Macrophages in Glioblastoma"],"prefix":"10.34133","volume":"8","author":[{"given":"Xuetong","family":"Li","sequence":"first","affiliation":[{"name":"The Affiliated Cancer Hospital of Xiangya School of Medicine, \rCentral South University\/Hunan Cancer Hospital, Changsha, China."},{"name":"The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, School of Basic Medicine, \rCentral South University, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[{"name":"The Affiliated Cancer Hospital of Xiangya School of Medicine, \rCentral South University\/Hunan Cancer Hospital, Changsha, China."},{"name":"The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, School of Basic Medicine, \rCentral South University, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmiao","family":"Long","sequence":"additional","affiliation":[{"name":"The Affiliated Cancer Hospital of Xiangya School of Medicine, \rCentral South University\/Hunan Cancer Hospital, Changsha, China."},{"name":"The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, School of Basic Medicine, \rCentral South University, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5547-907X","authenticated-orcid":true,"given":"Minghua","family":"Wu","sequence":"additional","affiliation":[{"name":"The Affiliated Cancer Hospital of Xiangya School of Medicine, \rCentral South University\/Hunan Cancer Hospital, Changsha, China."},{"name":"The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, School of Basic Medicine, \rCentral South University, Changsha, China."},{"name":"Xiangya School of Public Health, \rCentral South University, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noaf099","article-title":"Multimodal glioma immunotherapy combining TLR9-targeted STAT3 antisense oligodeoxynucleotides with PD1 immune checkpoint blockade","author":"Hung CY","year":"2025","unstructured":"Hung CY, Kang EY, Jacek K, Yu C, Zhang X, Zhu Y, Aftabizadeh M, Wong RA, Badie B, \u015awiderski P, et al. Multimodal glioma immunotherapy combining TLR9-targeted STAT3 antisense oligodeoxynucleotides with PD1 immune checkpoint blockade. Neuro-Oncology. 2025; Article noaf099.","journal-title":"Neuro-Oncology"},{"issue":"1","key":"e_1_3_2_3_2","doi-asserted-by":"crossref","DOI":"10.1007\/s44194-024-00031-y","article-title":"Glioma-associated macrophages: Unraveling their dual role in the microenvironment and therapeutic implications","volume":"3","author":"Wang J","year":"2024","unstructured":"Wang J, Li S, Lan Y, Liu X, Li W. Glioma-associated macrophages: Unraveling their dual role in the microenvironment and therapeutic implications. Curr Med. 2024;3(1): Article 4.","journal-title":"Curr Med"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4185"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.007"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.10.007"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-020-00789-y"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.10.052"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00397-3"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.09.007"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-235028"},{"issue":"1","key":"e_1_3_2_12_2","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163451","article-title":"Monocyte-neutrophil entanglement in glioblastoma","volume":"133","author":"Friedmann-Morvinski D","year":"2023","unstructured":"Friedmann-Morvinski D, Hambardzumyan D. Monocyte-neutrophil entanglement in glioblastoma. J Clin Invest. 2023;133(1): Article e163451.","journal-title":"J Clin Invest"},{"issue":"8","key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1161\/ATVBAHA.117.309145","article-title":"Human blood monocyte subsets: A new gating strategy defined using cell surface markers identified by mass cytometry","volume":"37","author":"Thomas GD","year":"2017","unstructured":"Thomas GD, Hamers AA, Nakao C, Marcovecchio P, Taylor AM, McSkimming C, Nguyen AT, McNamara CA, Hedrick CC. Human blood monocyte subsets: A new gating strategy defined using cell surface markers identified by mass cytometry. Arterioscler Thromb Vasc Biol. 2017;37(8):1548\u20131558.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.05.025"},{"issue":"6335","key":"e_1_3_2_15_2","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors","volume":"356","author":"Villani AC","year":"2017","unstructured":"Villani AC, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, Griesbeck M, Butler A, Zheng S, Lazo S, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356(6335): Article eaah4573.","journal-title":"Science"},{"issue":"4","key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI29919","article-title":"Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites","volume":"117","author":"Tsou CL","year":"2007","unstructured":"Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP, Mack M, Charo IF. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest. 2007;117(4):902\u2013909.","journal-title":"J Clin Invest"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1142883"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-021-09958-2"},{"issue":"1","key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40478-021-01163-0","article-title":"TNF\u03b1 secreted by glioma associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapy","volume":"9","author":"Wei Q","year":"2021","unstructured":"Wei Q, Singh O, Ekinci C, Gill J, Li M, Mamatjan Y, Karimi S, Bunda S, Mansouri S, Aldape K, et al. TNF\u03b1 secreted by glioma associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapy. Acta Neuropathol Commun. 2021;9(1):67.","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3171\/jns.1979.50.3.0305","article-title":"Macrophages in experimental and human brain tumors. Part 2: Studies of the macrophage content of human brain tumors","volume":"50","author":"Morantz RA","year":"1979","unstructured":"Morantz RA, Wood GW, Foster M, Clark M, Gollahon K. Macrophages in experimental and human brain tumors. Part 2: Studies of the macrophage content of human brain tumors. J Neurosurg. 1979;50(3):305\u2013311.","journal-title":"J Neurosurg"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11385","article-title":"The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages","volume":"7","author":"Yang Y","year":"2016","unstructured":"Yang Y, Andersson P, Hosaka K, Zhang Y, Cao R, Iwamoto H, Yang X, Nakamura M, Wang J, Zhuang R, et al. The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages. Nat Commun. 2016;7: Article 11385.","journal-title":"Nat Commun"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2310"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1902366116"},{"issue":"1","key":"e_1_3_2_24_2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman R","year":"2015","unstructured":"Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol. 2015;7(1): Article a020412.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2012.02.003"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00978","article-title":"Targeting VEGF\/VEGFR to modulate antitumor immunity","volume":"9","author":"Yang J","year":"2018","unstructured":"Yang J, Yan J, Liu B. Targeting VEGF\/VEGFR to modulate antitumor immunity. Front Immunol. 2018;9: Article 978.","journal-title":"Front Immunol"},{"issue":"6","key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.3892\/or.2016.5171","article-title":"Hypoxia and macrophages promote glioblastoma invasion by the CCL4-CCR5 axis","volume":"36","author":"Wang Y","year":"2016","unstructured":"Wang Y, Liu T, Yang N, Xu S, Li X, Wang D. Hypoxia and macrophages promote glioblastoma invasion by the CCL4-CCR5 axis. Oncol Rep. 2016;36(6):3522\u20133528.","journal-title":"Oncol Rep"},{"issue":"9","key":"e_1_3_2_28_2","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092257","article-title":"The interplay between glioblastoma and its microenvironment","volume":"10","author":"Dapash M","year":"2021","unstructured":"Dapash M, Hou D, Castro B, Lee-Chang C, Lesniak MS. The interplay between glioblastoma and its microenvironment. Cells. 2021;10(9): Article 2257.","journal-title":"Cells"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.703465","article-title":"A novel Oral arginase 1\/2 inhibitor enhances the antitumor effect of PD-1 inhibition in murine experimental gliomas by altering the immunosuppressive environment","volume":"11","author":"Pilanc P","year":"2021","unstructured":"Pilanc P, Wojnicki K, Roura AJ, Cyranowski S, Ellert-Miklaszewska A, Ochocka N, Gielniewski B, Grzybowski MM, B\u0142aszczyk R, Sta\u0144czak PS, et al. A novel Oral arginase 1\/2 inhibitor enhances the antitumor effect of PD-1 inhibition in murine experimental gliomas by altering the immunosuppressive environment. Front Oncologia. 2021;11: Article 703465.","journal-title":"Front Oncologia"},{"issue":"1","key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11060-019-03221-z","article-title":"Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma","volume":"144","author":"Morimoto Y","year":"2019","unstructured":"Morimoto Y, Tamura R, Ohara K, Kosugi K, Oishi Y, Kuranari Y, Yoshida K, Toda M. Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma. J Neuro-Oncol. 2019;144(1):65\u201377.","journal-title":"J Neuro-Oncol"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.biomaterials.2018.01.053","article-title":"Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis","volume":"161","author":"Cui X","year":"2018","unstructured":"Cui X, Morales RT, Qian W, Wang H, Gagner JP, Dolgalev I, Placantonakis D, Zagzag D, Cimmino L, Snuderl M, et al. Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis. Biomaterials. 2018;161:164\u2013178.","journal-title":"Biomaterials"},{"issue":"38","key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1038\/onc.2017.145","article-title":"CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma","volume":"36","author":"Zhu C","year":"2017","unstructured":"Zhu C, Chrifi I, Mustafa D, van der Weiden M, Leenen PJM, Duncker DJ, Kros JM, Cheng C. CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma. Oncogene. 2017;36(38):5356\u20135368.","journal-title":"Oncogene"},{"issue":"1","key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4049\/jimmunol.1103248","article-title":"Tumor-associated microglia\/macrophages enhance the invasion of glioma stem-like cells via TGF-\u03b21 signaling pathway","volume":"189","author":"Ye XZ","year":"2012","unstructured":"Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, Chen L, Xiao HL, Wang B, Yi L, Wang QL, et al. Tumor-associated microglia\/macrophages enhance the invasion of glioma stem-like cells via TGF-\u03b21 signaling pathway. J Immunol. 2012;189(1):444\u2013453.","journal-title":"J Immunol"},{"issue":"1","key":"e_1_3_2_34_2","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15080","article-title":"Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth","volume":"8","author":"Shi Y","year":"2017","unstructured":"Shi Y, Ping YF, Zhou W, He ZC, Chen C, Bian BS, Zhang L, Chen L, Lan X, Zhang XC, et al. Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth. Nat Commun. 2017;8(1): Article 15080.","journal-title":"Nat Commun"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2018.06.023"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","DOI":"10.34133\/research.0211","article-title":"Supramolecular biomaterials for cancer immunotherapy","volume":"6","author":"Liang H","year":"2023","unstructured":"Liang H, Lu Q, Yang J, Yu G. Supramolecular biomaterials for cancer immunotherapy. Research. 2023;6: Article 0211.","journal-title":"Research"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature10491"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1912"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2016.09.013","article-title":"CD4+Foxp3- type 1 regulatory T cells in glioblastoma multiforme suppress T cell responses through multiple pathways and are regulated by tumor-associated macrophages","volume":"81","author":"Li Z","year":"2016","unstructured":"Li Z, Liu X, Guo R, Wang P. CD4+Foxp3- type 1 regulatory T cells in glioblastoma multiforme suppress T cell responses through multiple pathways and are regulated by tumor-associated macrophages. Int J Biochem Cell Biol. 2016;81(Pt A):1\u20139.","journal-title":"Int J Biochem Cell Biol"},{"issue":"12","key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1158\/1078-0432.CCR-12-3314","article-title":"Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages","volume":"19","author":"Bloch O","year":"2013","unstructured":"Bloch O, Crane CA, Kaur R, Safaee M, Rutkowski MJ, Parsa AT. Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages. Clin Cancer Res. 2013;19(12):3165\u20133175.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0858"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0297"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3726"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00691","article-title":"Clinical relevance and immunosuppressive pattern of circulating and infiltrating subsets of myeloid-derived suppressor cells (MDSCs) in epithelial ovarian cancer","volume":"10","author":"Ok\u0142a K","year":"2019","unstructured":"Ok\u0142a K, Czerwonka A, Wawruszak A, Bobi\u0144ski M, Bilska M, Tarkowski R, Bednarek W, Wertel I, Kotarski J. Clinical relevance and immunosuppressive pattern of circulating and infiltrating subsets of myeloid-derived suppressor cells (MDSCs) in epithelial ovarian cancer. Front Immunol. 2019;10: Article 691.","journal-title":"Front Immunol"},{"issue":"1","key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","article-title":"Myeloid-derived suppressor cells: An emerging target for anticancer immunotherapy","volume":"21","author":"Wu Y","year":"2022","unstructured":"Wu Y, Yi M, Niu M, Mei Q, Wu K. Myeloid-derived suppressor cells: An emerging target for anticancer immunotherapy. Mol Cancer. 2022;21(1):184.","journal-title":"Mol Cancer"},{"issue":"3","key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ccell.2023.02.009","article-title":"Functional states of myeloid cells in cancer","volume":"41","author":"Vlerken-Ysla L","year":"2023","unstructured":"van Vlerken-Ysla L, Tyurina YY, Kagan VE, Gabrilovich DI. Functional states of myeloid cells in cancer. Cancer Cell. 2023;41(3):490\u2013504.","journal-title":"Cancer Cell"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.04.004"},{"issue":"1","key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11060-017-2508-7","article-title":"The ratio of HLA-DR and VNN2+ expression on CD14+ myeloid derived suppressor cells can distinguish glioblastoma from radiation necrosis patients","volume":"134","author":"Soler DC","year":"2017","unstructured":"Soler DC, Young AB, Cooper KD, Kerstetter-Fogle A, Barnholtz-Sloan JS, Gittleman H, McCormick TS, Sloan AE. The ratio of HLA-DR and VNN2+ expression on CD14+ myeloid derived suppressor cells can distinguish glioblastoma from radiation necrosis patients. J Neuro-Oncol. 2017;134(1):189\u2013196.","journal-title":"J Neuro-Oncol"},{"issue":"11","key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1002\/eji.201343472","article-title":"Polyunsaturated fatty acids promote the expansion of myeloid-derived suppressor cells by activating the JAK\/STAT3 pathway","volume":"43","author":"Yan D","year":"2013","unstructured":"Yan D, Yang Q, Shi M, Zhong L, Wu C, Meng T, Yin H, Zhou J. Polyunsaturated fatty acids promote the expansion of myeloid-derived suppressor cells by activating the JAK\/STAT3 pathway. Eur J Immunol. 2013;43(11):2943\u20132955.","journal-title":"Eur J Immunol"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.05.034"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0465"},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","unstructured":"Gabrusiewicz K Colwell NA Heimberger AB. Chapter\u00a04\u2014The role of myeloid-derived suppressor cells in immunosuppression in brain tumors. In: Sampson JH editor. Translational immunotherapy of brain tumors. Academic Press; 2017. p. 63\u201382.","DOI":"10.1016\/B978-0-12-802420-1.00004-1"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.06.032"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.05.002"},{"issue":"1","key":"e_1_3_2_56_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03050-0","article-title":"Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2\u03b1","volume":"9","author":"Wang Q","year":"2018","unstructured":"Wang Q, He Z, Huang M, Liu T, Wang Y, Xu H, Duan H, Ma P, Zhang L, Zamvil SS, et al. Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2\u03b1. Nat Commun. 2018;9(1): Article 559.","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_2_57_2","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3096","article-title":"Chemical vapour deposition growth of large single crystals of monolayer and bilayer graphene","volume":"4","author":"Zhou H","year":"2013","unstructured":"Zhou H, Yu WJ, Liu L, Cheng R, Chen Y, Huang X, Liu Y, Wang Y, Huang Y, Duan X. Chemical vapour deposition growth of large single crystals of monolayer and bilayer graphene. Nat Commun. 2013;4(1): Article 2096.","journal-title":"Nat Commun"},{"issue":"8","key":"e_1_3_2_58_2","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12081533","article-title":"Bradykinin B1 receptor affects tumor-associated macrophage activity and glioblastoma progression","volume":"12","author":"Shen CK","year":"2023","unstructured":"Shen CK, Huang BR, Charoensaensuk V, Yang LY, Tsai CF, Liu YS, Lu DY, Yeh WL, Lin C. Bradykinin B1 receptor affects tumor-associated macrophage activity and glioblastoma progression. Antioxidants. 2023;12(8): Article 1533.","journal-title":"Antioxidants"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2913"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.03.013"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.03.029"},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jare.2025.05.032","article-title":"Targeting mesenchymal monocyte-derived macrophages to enhance the sensitivity of glioblastoma to temozolomide by inhibiting TNF\/CELSR2\/p65\/Kla-HDAC1\/EPAS1 axis","author":"Gao W","year":"2025","unstructured":"Gao W, Long X, Lin X, Deng K, Li D, Huang M, Wang X, Liu Q, Wu M. Targeting mesenchymal monocyte-derived macrophages to enhance the sensitivity of glioblastoma to temozolomide by inhibiting TNF\/CELSR2\/p65\/Kla-HDAC1\/EPAS1 axis. J Adv Res. 2025.","journal-title":"J Adv Res"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.11.007"},{"issue":"8","key":"e_1_3_2_64_2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.32604\/or.2024.052130","article-title":"Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in glioblastoma multiforme: A systematic review going beyond pathologic implications","volume":"32","author":"Vageli DP","unstructured":"Vageli DP, Doukas PG, Goupou K, Benos AD, Astara K, Zacharouli K, Sotiriou S, Ioannou M. Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in glioblastoma multiforme: A systematic review going beyond pathologic implications. Oncol Res. 32(8):1239\u20131256.","journal-title":"Oncol Res"},{"issue":"4","key":"e_1_3_2_65_2","doi-asserted-by":"crossref","DOI":"10.3390\/cells6040045","article-title":"The role of hypoxia in glioblastoma invasion","volume":"6","author":"Monteiro AR","year":"2017","unstructured":"Monteiro AR, Hill R, Pilkington GJ, Madureira PA. The role of hypoxia in glioblastoma invasion. Cells. 2017;6(4): Article 45.","journal-title":"Cells"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0196"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.02.009"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-2994"},{"issue":"1","key":"e_1_3_2_69_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33349-y","article-title":"CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis","volume":"13","author":"Yang P","year":"2022","unstructured":"Yang P, Qin H, Li Y, Xiao A, Zheng E, Zeng H, Su C, Luo X, Lu Q, Liao M, et al. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis. Nat Commun. 2022;13(1): Article 5782.","journal-title":"Nat Commun"},{"issue":"4","key":"e_1_3_2_70_2","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.395","article-title":"FABP4 deactivates NF-\u03baB-IL1\u03b1 pathway by ubiquitinating ATPB in tumor-associated macrophages and promotes neuroblastoma progression","volume":"11","author":"Miao L","year":"2021","unstructured":"Miao L, Zhuo Z, Tang J, Huang X, Liu J, Wang HY, Xia H, He J. FABP4 deactivates NF-\u03baB-IL1\u03b1 pathway by ubiquitinating ATPB in tumor-associated macrophages and promotes neuroblastoma progression. Clin Transl Med. 2021;11(4): Article e395.","journal-title":"Clin Transl Med"},{"key":"e_1_3_2_71_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12950-020-00254-4","article-title":"Potential interaction between lysophosphatidic acid and tumor-associated macrophages in ovarian carcinoma","volume":"17","author":"Feng Y","year":"2020","unstructured":"Feng Y, Xiao M, Zhang Z, Cui R, Jiang X, Wang S, Bai H, Liu C, Zhang Z. Potential interaction between lysophosphatidic acid and tumor-associated macrophages in ovarian carcinoma. J Inflamm. 2020;17:23.","journal-title":"J Inflamm"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/cns.13899"},{"key":"e_1_3_2_73_2","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10905","article-title":"Microglial P2Y12 is necessary for synaptic plasticity in mouse visual cortex","volume":"7","author":"Sipe GO","year":"2016","unstructured":"Sipe GO, Lowery RL, Tremblay M\u00c8, Kelly EA, Lamantia CE, Majewska AK. Microglial P2Y12 is necessary for synaptic plasticity in mouse visual cortex. Nat Commun. 2016;7: Article 10905.","journal-title":"Nat Commun"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2511"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.679043"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-176891"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1609896113"},{"issue":"6","key":"e_1_3_2_78_2","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.4049\/jimmunol.1302379","article-title":"IFN-\u03b3 primes macrophage activation by increasing phosphatase and tensin homolog via downregulation of miR-3473b","volume":"193","author":"Wu C","year":"2014","unstructured":"Wu C, Xue Y, Wang P, Lin L, Liu Q, Li N, Xu J, Cao X. IFN-\u03b3 primes macrophage activation by increasing phosphatase and tensin homolog via downregulation of miR-3473b. J Immunol. 2014;193(6):3036\u20133044.","journal-title":"J Immunol"},{"issue":"2","key":"e_1_3_2_79_2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.immuni.2019.06.017","article-title":"Treg cells promote the SREBP1-dependent metabolic fitness of tumor-promoting macrophages via repression of CD8+ T cell-derived interferon-\u03b3","volume":"51","author":"Liu C","year":"2019","unstructured":"Liu C, Chikina M, Deshpande R, Menk AV, Wang T, Tabib T, Brunazzi EA, Vignali KM, Sun M, Stolz DB, et al. Treg cells promote the SREBP1-dependent metabolic fitness of tumor-promoting macrophages via repression of CD8+ T cell-derived interferon-\u03b3. Immunity. 2019;51(2):381\u2013397.","journal-title":"Immunity"},{"issue":"5","key":"e_1_3_2_80_2","first-page":"1940","article-title":"Lymphocyte supernatant-induced human monocyte tumoricidal activity: Dependence on the presence of gamma-interferon","volume":"45","author":"Sadlik JR","year":"1985","unstructured":"Sadlik JR, Hoyer M, Leyko MA, Horvat R, Parmely M, Whitacre C, Zwilling B, Rinehart JJ. Lymphocyte supernatant-induced human monocyte tumoricidal activity: Dependence on the presence of gamma-interferon. Cancer Res. 1985;45(5):1940\u20131945.","journal-title":"Cancer Res"},{"issue":"1","key":"e_1_3_2_81_2","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms1239","article-title":"Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer","volume":"2","author":"Haabeth OA","year":"2011","unstructured":"Haabeth OA, Lorvik KB, Hammarstr\u00f6m C, Donaldson IM, Haraldsen G, Bogen B, Corthay A. Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer. Nat Commun. 2011;2(1): Article 240.","journal-title":"Nat Commun"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1937"},{"issue":"5","key":"e_1_3_2_83_2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.7150\/ijbs.7.651","article-title":"Dual roles of immune cells and their factors in cancer development and progression","volume":"7","author":"Zamarron BF","year":"2011","unstructured":"Zamarron BF, Chen W. Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci. 2011;7(5):651\u2013658.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"e_1_3_2_84_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41421-022-00403-4","article-title":"Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3","volume":"8","author":"Shao Z","year":"2022","unstructured":"Shao Z, Tan Y, Shen Q, Hou L, Yao B, Qin J, Xu P, Mao C, Chen LN, Zhang H, et al. Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3. Cell Discov. 2022;8(1):44.","journal-title":"Cell Discov"},{"issue":"1","key":"e_1_3_2_85_2","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: Heterogeneity, plasticity, and therapy","volume":"133","author":"Khan F","year":"2023","unstructured":"Khan F, Pang L, Dunterman M, Lesniak MS, Heimberger AB, Chen P. Macrophages and microglia in glioblastoma: Heterogeneity, plasticity, and therapy. J Clin Invest. 2023;133(1): Article e163446.","journal-title":"J Clin Invest"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2007.10.003"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01267-2"},{"issue":"3","key":"e_1_3_2_88_2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s10637-012-9869-8","article-title":"Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer","volume":"31","author":"Pienta KJ","year":"2013","unstructured":"Pienta KJ, Machiels JP, Schrijvers D, Alekseev B, Shkolnik M, Crabb SJ, Li S, Seetharam S, Puchalski TA, Takimoto C, et al. Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer. Investig New Drugs. 2013;31(3):760\u2013768.","journal-title":"Investig New Drugs"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-019-0370-y"},{"issue":"1","key":"e_1_3_2_90_2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI121266","article-title":"Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target","volume":"129","author":"Wei J","year":"2019","unstructured":"Wei J, Marisetty A, Schrand B, Gabrusiewicz K, Hashimoto Y, Ott M, Grami Z, Kong LY, Ling X, Caruso H, et al. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target. J Clin Invest. 2019;129(1):137\u2013149.","journal-title":"J Clin Invest"},{"issue":"16","key":"e_1_3_2_91_2","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141083","article-title":"SLIT2\/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia","volume":"131","author":"Geraldo LH","year":"2021","unstructured":"Geraldo LH, Xu Y, Jacob L, Pibouin-Fragner L, Rao R, Maissa N, Verreault M, Lemaire N, Knosp C, Lesaffre C, et al. SLIT2\/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia. J Clin Invest. 2021;131(16): Article e141083.","journal-title":"J Clin Invest"},{"issue":"16","key":"e_1_3_2_92_2","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2009290118","article-title":"PI3K\u03b3 inhibition suppresses microglia\/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response","volume":"118","author":"Li J","year":"2021","unstructured":"Li J, Kaneda MM, Ma J, Li M, Shepard RM, Patel K, Koga T, Sarver A, Furnari F, Xu B, et al. PI3K\u03b3 inhibition suppresses microglia\/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response. Proc Natl Acad Sci USA. 2021;118(16): Article e2009290118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0400"},{"issue":"381","key":"e_1_3_2_94_2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2968","article-title":"Disrupting the CD47-SIRP\u03b1 anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors","volume":"9","author":"Gholamin S","year":"2017","unstructured":"Gholamin S, Mitra SS, Feroze AH, Liu J, Kahn SA, Zhang M, Esparza R, Richard C, Ramaswamy V, Remke M, et al. Disrupting the CD47-SIRP\u03b1 anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Sci Transl Med. 2017;9(381): Article eaaf2968.","journal-title":"Sci Transl Med"},{"issue":"2","key":"e_1_3_2_95_2","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1073\/pnas.1910856117","article-title":"CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas","volume":"117","author":"Flores-Toro JA","year":"2020","unstructured":"Flores-Toro JA, Luo D, Gopinath A, Sarkisian MR, Campbell JJ, Charo IF, Singh R, Schall TJ, Datta M, Jain RK, et al. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas. Proc Natl Acad Sci USA. 2020;117(2):1129\u20131138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1721434116"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00271-4"},{"issue":"1","key":"e_1_3_2_98_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15129-8","article-title":"Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity","volume":"11","author":"Roemeling CA","year":"2020","unstructured":"von Roemeling CA, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, Yang Z, Yang M, Deng W, Bruno KA, et al. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020;11(1): Article 1508.","journal-title":"Nat Commun"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02018"},{"issue":"2","key":"e_1_3_2_100_2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/cncr.22402","article-title":"Antibody constructs in cancer therapy: Protein engineering strategies to improve exposure in solid tumors","volume":"109","author":"Beckman RA","year":"2007","unstructured":"Beckman RA, Weiner LM, Davis HM. Antibody constructs in cancer therapy: Protein engineering strategies to improve exposure in solid tumors. Cancer. 2007;109(2):170\u2013179.","journal-title":"Cancer"},{"issue":"1","key":"e_1_3_2_101_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29137-3","article-title":"Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion","volume":"13","author":"Jiang N","year":"2022","unstructured":"Jiang N, Xie B, Xiao W, Fan M, Xu S, Duan Y, Hamsafar Y, Evans AC, Huang J, Zhou W, et al. Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion. Nat Commun. 2022;13(1): Article 1511.","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_2_102_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26003-6","article-title":"An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma","volume":"12","author":"Xu B","year":"2021","unstructured":"Xu B, Tian L, Chen J, Wang J, Ma R, Dong W, Li A, Zhang J, Antonio Chiocca E, Kaur B, et al. An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma. Nat Commun. 2021;12(1): Article 5908.","journal-title":"Nat Commun"},{"key":"e_1_3_2_103_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.777524","article-title":"Imaging of glioblastoma tumor-associated myeloid cells using nanobodies targeting signal regulatory protein alpha","volume":"12","author":"De Vlaminck K","year":"2021","unstructured":"De Vlaminck K, Rom\u00e3o E, Puttemans J, Pombo Antunes AR, Kancheva D, Scheyltjens I, Van Ginderachter JA, Muyldermans S, Devoogdt N, Movahedi K, et al. Imaging of glioblastoma tumor-associated myeloid cells using nanobodies targeting signal regulatory protein alpha. Front Immunol. 2021;12: Article 777524.","journal-title":"Front Immunol"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.02.040"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.261"},{"issue":"4","key":"e_1_3_2_106_2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/neuonc\/nov245","article-title":"Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: An Ivy Foundation Early Phase Clinical Trials Consortium phase II study","volume":"18","author":"Butowski N","year":"2016","unstructured":"Butowski N, Colman H, De Groot JF, Omuro AM, Nayak L, Wen PY, Cloughesy TF, Marimuthu A, Haidar S, Perry A, et al. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: An Ivy Foundation Early Phase Clinical Trials Consortium phase II study. Neuro-Oncology. 2016;18(4):557\u2013564.","journal-title":"Neuro-Oncology"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.217"},{"issue":"6288","key":"e_1_3_2_108_2","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad3018","article-title":"The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas","volume":"352","author":"Quail DF","year":"2016","unstructured":"Quail DF, Bowman RL, Akkari L, Quick ML, Schuhmacher AJ, Huse JT, Holland EC, Sutton JC, Joyce JA. The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas. Science. 2016;352(6288): Article aad3018.","journal-title":"Science"},{"key":"e_1_3_2_109_2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52253","article-title":"Dissecting the immunosuppressive tumor microenvironments in glioblastoma-on-a-Chip for optimized PD-1 immunotherapy","volume":"9","author":"Cui X","year":"2020","unstructured":"Cui X, Ma C, Vasudevaraja V, Serrano J, Tong J, Peng Y, Delorenzo M, Shen G, Frenster J, Morales RT, et al. Dissecting the immunosuppressive tumor microenvironments in glioblastoma-on-a-Chip for optimized PD-1 immunotherapy. eLife. 2020;9: Article e52253.","journal-title":"eLife"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3337"},{"key":"e_1_3_2_111_2","doi-asserted-by":"crossref","DOI":"10.34133\/research.0450","article-title":"Targeting the cascade amplification of macrophage colony-stimulating factor to alleviate the immunosuppressive effects following radiotherapy","volume":"7","author":"Liao Z","year":"2024","unstructured":"Liao Z, Wang Y, Yang Y, Liu X, Yang X, Tian Y, Deng S, Hu Y, Meng J, Li J, et al. Targeting the cascade amplification of macrophage colony-stimulating factor to alleviate the immunosuppressive effects following radiotherapy. Research. 2024;7: Article 0450.","journal-title":"Research"},{"issue":"1","key":"e_1_3_2_112_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16789-2","article-title":"ARS2\/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages","volume":"11","author":"Yin J","year":"2020","unstructured":"Yin J, Kim SS, Choi E, Oh YT, Lin W, Kim TH, Sa JK, Hong JH, Park SH, Kwon HJ, et al. ARS2\/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages. Nat Commun. 2020;11(1): Article 2978.","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_2_113_2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-022-02349-7","article-title":"Emerging therapies for glioblastoma: Current state and future directions","volume":"41","author":"Rong L","year":"2022","unstructured":"Rong L, Li N, Zhang Z. Emerging therapies for glioblastoma: Current state and future directions. J Exp Clin Cancer Res. 2022;41(1):142.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"e_1_3_2_114_2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-022-00894-3","article-title":"Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects","volume":"7","author":"Wang X","year":"2022","unstructured":"Wang X, Ding H, Li Z, Peng Y, Tan H, Wang C, Huang G, Li W, Ma G, Wei W. Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects. Signal Transduct Target Ther. 2022;7(1):74.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"e_1_3_2_115_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23832-3","article-title":"Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40","volume":"12","author":"Yang F","year":"2021","unstructured":"Yang F, He Z, Duan H, Zhang D, Li J, Yang H, Dorsey JF, Zou W, Nabavizadeh SA, Bagley SJ, et al. Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40. Nat Commun. 2021;12(1): Article 3424.","journal-title":"Nat Commun"},{"issue":"656","key":"e_1_3_2_116_2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn1128","article-title":"Intracavity generation of glioma stem cell\u2013specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy","volume":"14","author":"Chen C","year":"2022","unstructured":"Chen C, Jing W, Chen Y, Wang G, Abdalla M, Gao L, Han M, Shi C, Li A, Sun P, et al. Intracavity generation of glioma stem cell\u2013specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy. Sci Transl Med. 2022;14(656): Article eabn1128.","journal-title":"Sci Transl Med"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01687-8"},{"key":"e_1_3_2_118_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1532528","article-title":"Combination of sodium butyrate and immunotherapy in glioma: Regulation of immunologically hot and cold tumors via gut microbiota and metabolites","volume":"16","author":"Li S","year":"2025","unstructured":"Li S, Wang L, Han M, Fan H, Tang H, Gao H, Li G, Xu Z, Zhou Z, Du J, et al. Combination of sodium butyrate and immunotherapy in glioma: Regulation of immunologically hot and cold tumors via gut microbiota and metabolites. Front Immunol. 2025;16: Article 1532528.","journal-title":"Front Immunol"},{"issue":"22","key":"e_1_3_2_119_2","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1158\/1078-0432.CCR-12-2130","article-title":"IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival","volume":"18","author":"Wainwright DA","year":"2012","unstructured":"Wainwright DA, Balyasnikova IV, Chang AL, Ahmed AU, Moon KS, Auffinger B, Tobias AL, Han Y, Lesniak MS. IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival. Clin Cancer Res. 2012;18(22):6110\u20136121.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"e_1_3_2_120_2","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1158\/1078-0432.CCR-17-3573","article-title":"IDO1 inhibition synergizes with radiation and PD-1 blockade to durably increase survival against advanced glioblastoma","volume":"24","author":"Ladomersky E","year":"2018","unstructured":"Ladomersky E, Zhai L, Lenzen A, Lauing KL, Qian J, Scholtens DM, Gritsina G, Sun X, Liu Y, Yu F, et al. IDO1 inhibition synergizes with radiation and PD-1 blockade to durably increase survival against advanced glioblastoma. Clin Cancer Res. 2018;24(11):2559\u20132573.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"e_1_3_2_121_2","doi-asserted-by":"crossref","DOI":"10.31083\/FBL36348","article-title":"An MRI radiogenomic signature to characterize the transcriptional heterogeneity associated with prognosis and biological functions in glioblastoma","volume":"30","author":"Zhang X","year":"2025","unstructured":"Zhang X, Zhang X, Zhu J, Yi Z, Cao H, Tang H, Zhang H, Huang G. An MRI radiogenomic signature to characterize the transcriptional heterogeneity associated with prognosis and biological functions in glioblastoma. Front Biosci. 2025;30(3): Article 36348.","journal-title":"Front Biosci"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.12.6166"},{"issue":"3","key":"e_1_3_2_123_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031808","article-title":"Tumor-associated macrophages\/microglia in glioblastoma oncolytic virotherapy: A double-edged sword","volume":"23","author":"Blitz SE","year":"2022","unstructured":"Blitz SE, Kappel AD, Gessler FA, Klinger NV, Arnaout O, Lu Y, Peruzzi PP, Smith TR, Chiocca EA, Friedman GK, et al. Tumor-associated macrophages\/microglia in glioblastoma oncolytic virotherapy: A double-edged sword. Int J Mol Sci. 2022;23(3): Article 1808.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri3088"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.04.008"},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.4.2011"},{"issue":"16","key":"e_1_3_2_127_2","doi-asserted-by":"crossref","first-page":"9055","DOI":"10.1111\/jcmm.15542","article-title":"FDPS promotes glioma growth and macrophage recruitment by regulating CCL20 via Wnt\/\u03b2-catenin signalling pathway","volume":"24","author":"Chen Z","year":"2020","unstructured":"Chen Z, Chen G, Zhao H. FDPS promotes glioma growth and macrophage recruitment by regulating CCL20 via Wnt\/\u03b2-catenin signalling pathway. J Cell Mol Med. 2020;24(16):9055\u20139066.","journal-title":"J Cell Mol Med"},{"key":"e_1_3_2_128_2","article-title":"Sequence-defined nanotubes assembled from IR780-conjugated peptoids for chemophototherapy of malignant glioma","volume":"2021","author":"Cai X","year":"2021","unstructured":"Cai X, Wang M, Mu P, Jian T, Liu D, Ding S, Luo Y, Du D, Song Y, Chen CL, et al. Sequence-defined nanotubes assembled from IR780-conjugated peptoids for chemophototherapy of malignant glioma. Research. 2021;2021: Article 9861384.","journal-title":"Research"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00620-6"},{"issue":"5","key":"e_1_3_2_130_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25053040","article-title":"Glioblastoma: An update in pathology, molecular mechanisms and biomarkers","volume":"25","author":"Lan Z","year":"2024","unstructured":"Lan Z, Li X, Zhang X. Glioblastoma: An update in pathology, molecular mechanisms and biomarkers. Int J Mol Sci. 2024;25(5): Article 3040.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.12.015"},{"key":"e_1_3_2_132_2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01083","article-title":"LCTL is a prognostic biomarker and correlates with stromal and immune infiltration in gliomas","volume":"9","author":"Su J","year":"2019","unstructured":"Su J, Ma Q, Long W, Tang H, Wu C, Luo M, Wang X, Xiao K, Li Y, Xiao Q, et al. LCTL is a prognostic biomarker and correlates with stromal and immune infiltration in gliomas. Front Oncol. 2019;9: Article 1083.","journal-title":"Front Oncol"},{"key":"e_1_3_2_133_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2023.111801","article-title":"Impact of age and gender on glioblastoma onset, progression, and management","volume":"211","author":"Colopi A","year":"2023","unstructured":"Colopi A, Fuda S, Santi S, Onorato A, Cesarini V, Salvati M, Balistreri CR, Dolci S, Guida E. Impact of age and gender on glioblastoma onset, progression, and management. Mech Ageing Dev. 2023;211: Article 111801.","journal-title":"Mech Ageing Dev"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201302627"}],"container-title":["Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.34133\/research.0836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T08:00:33Z","timestamp":1754985633000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.34133\/research.0836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":133,"alternative-id":["10.34133\/research.0836"],"URL":"https:\/\/doi.org\/10.34133\/research.0836","relation":{},"ISSN":["2639-5274"],"issn-type":[{"value":"2639-5274","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2025-03-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"0836"}}